Lichtsteiner Foundation
Overview
A charitable, tax-exempt, independent foundation under Swiss law that invests in early-stage start-ups in the medtech, life science, biotech, mental health, public health, and well-being sectors. The foundation's stated purpose is to promote discoveries in the field of medicine for the improvement of people's health. It typically supports 1-4 start-ups per year.
Portfolio Companies
13
Website
lichtsteinerfoundation.orgInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Allegria Therapeutics AG | Dec 2025 | Seed | Co-investor |
| DigeHealth SA | Dec 2025 | Seed | Co-investor |
| HemostOD SA | Oct 2025 | Seed | Co-investor |
| SEITO Biologics AG | Jun 2025 | Early Funding | Co-investor |
| Limula | May 2024 | Seed | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
